Gene-Edited Pig Kidney Transplants Reach Major Milestone as Patients Progress to Human Organs
Quick Brief
Patients who received groundbreaking gene-edited pig kidney transplants have successfully operated with the animal organs for extended periods. One patient lived with the world's first pig kidney transplant for nine months, lasting 271 days, before ultimately progressing to a human kidney transplant.
What Happened?
Medical history was made as patients successfully received gene-edited pig kidneys that functioned within the human body. One notable recipient lived with the animal organ for nine months, amounting to 271 days, before successfully transitioning to receive a human kidney.
Why It Matters
The successful integration and prolonged functioning of pig kidneys in human bodies represent a significant advancement in xenotransplantation, potentially offering a bridge or future solution to severe human organ shortages.
Key Facts
- Patients received gene-edited pig kidneys that functioned successfully in the human body.
- One patient lived with the world's first pig kidney transplant for nine months (271 days).
- The patient who received the initial pig kidney has successfully progressed to a human kidney transplant.
- The medical milestone highlights the potential future of xenotransplantation in addressing organ shortages.
Compiled from 1 outlet
Related Stories
Growing Scrutiny and Social Stigma Surround Mass-Prescribed GLP-1 Medications
The widespread prescription of GLP-1 medications has triggered growing public scrutiny and social debate. Experts are increasingly calling for safer weight loss practices as patients report facing intense social shaming and pressure regarding their use or non-use of the drugs.
New Zealand Approves MDMA Prescription for Severe PTSD Treatment
New Zealand health authorities have granted approval for two psychiatrists to prescribe pharmaceutical-grade MDMA. The substance will be used to treat patients suffering from severe post-traumatic stress disorder. This decision marks a significant shift in the medical application of the psychoactive compound.
New Zealand Approves MDMA Treatment for Severe PTSD
New Zealand's drug regulatory body, Medsafe, has granted approval for two psychiatrists to prescribe pharmaceutical-grade MDMA for severe post-traumatic stress disorder. This decision makes New Zealand the second country globally to approve the psychedelic substance for therapeutic use, following Australia's similar authorization in 2023.
Scientific Study Reveals Inaccuracies in Smartwatch Calorie Tracking
Recent scientific research highlights significant inaccuracies in how smartwatches measure calorie burn during physical activity. Evaluating four major brands, studies indicate that users cannot fully trust these health metrics, with Garmin showing the least accurate performance.